Fresenius Medical Care Springs into Action After Deadly Tianjin Explosion

HONG KONG, CHINA - Media OutReach - August 21, 2015 - Fresenius Medical Care -- THE RENAL COMPANY reacted immediately to the disaster, donating vital medical supplies to local hospitals and medical centers.

 

On August 12 a massive explosion ripped through Tianjin port leaving behind a trail of death and destruction;  officials now state 114 people were killed in the blast, with many more being left injured and homeless.  Rescue efforts have been immediate but difficult, with many emergency staff and volunteers losing their lives in the process. 

 

Fresenius Medical Care China has prioritized rescue efforts after the disaster and staff at the Tianjin office gave their time throughout the night of the explosion to register at all the hospitals and co-ordinate the donation of much-needed equipment.  As a result, the next day medical supplies totalling over RMB 1 million were rushed to Tianjin, including three advanced CRRT MultiFiltrate/Ci Ca machines; two of which have been used for the immediate relief of injured patients at Tianjin Fifth Center Hospital.  A further five acute devices were successfully transported to Tianjin on August 14. The MultiFiltrate/Ci Ca CRRT machines use advanced technology and are a vital lifeline to patients undergoing acute renal replacement/multi-organ support therapy as well as supporting patients with burns and other injuries caused in the explosion.

 

Mr. Chen Yugang Alan, president of Fresenius Medical Care China, has said of the situation: "As the world leader in renal care, Fresenius Medical Care is committed to help those in need and history of  supporting in critical times of emergency rescue and disaster relief such as the Wenchuan earthquake, Yushu earthquake and Kunshan explosion."

 

Company logo

http://release.media-outreach.com/i/Download/1869

 

ABOUT FRESENIUS MEDICAL CARE: Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 2.7 million individuals worldwide. Through its network of 3,361 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatments for 286,312 patients around the globe. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. For more information visit the Company’s website at www.freseniusmedicalcare.com. Disclaimer This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.